CNSP - Cns Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNSP is currently covered by 1 analysts with an average price target of $20.86. This is a potential upside of $12.61 (152.85%) from yesterday's end of day stock price of $8.25.

Cns Pharmaceuticals's activity chart (see below) currently has 1 price targets and 3 ratings on display. The stock rating distribution of CNSP is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 196 days.

Highest price target for CNSP is $20, Lowest price target is $20, average price target is $20.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 12-Sep-2025. First documented stock forecast 10-Sep-2024.

Best performing analysts who are covering CNSP - Cns Pharmaceuticals:

Jason Mccarthy

Currently out of the existing stock ratings of CNSP, 1 are a HOLD (50%), 1 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$20

$11.75 (142.42%)

1 months 13 days ago
(12-Sep-2025)

1/2 (50%)

$12.61 (170.64%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNSP (Cns Pharmaceuticals) average time for price targets to be met?

On average it took 196 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on CNSP (Cns Pharmaceuticals) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on CNSP (Cns Pharmaceuticals)?

Jason Mccarthy works at MAXIM GROUP and has 0 price targets and 0 ratings on CNSP

Which analyst is the currently most bullish on CNSP (Cns Pharmaceuticals)?

Jason Mccarthy with highest potential upside - $11.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?